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While frank obesity is associated with reduced HRV, indicative of poorer autonomic nervous system (ANS) function, the
association between body mass index (BMI) and HRV is less clear. We hypothesized that effects of adiposity on ANS are mostly
mediated by visceral fat and less by subcutaneous fat; therefore, centrally distributed adipose tissue, that is, waist circumference
(WC), should be more strongly associated with HRV than overall adiposity (BMI). To examine this hypothesis, we used data
collected in a subset of the Baltimore Longitudinal Study of Aging to compare strength of association between HRV and WC to
that of HRV and BMI. Time domain HRV variables SDNN (standard deviation of successive differences in normal-to-normal
(N-N) intervals) and RMSSD (root mean square of successive differences in N-N intervals) were calculated from 24-hour Holter
recordings in 159 participants (29–96 years). Increasing WC was associated with decreasing SDNN and RMSSD in younger but
not older participants (P value for WC-by-age interaction= 0.003). BMI was not associated with either SDNN or RMSSD at any
age. In conclusion, central adiposity may contribute to sympathetic and parasympathetic ANS declines early in life.
1. Introduction
The autonomic nervous system (ANS) directs voluntary
and involuntary physiologic processes such as digestion,
blood pressure, hormonal regulation, energy metabolism,
and heart rate and is therefore considered an important
regulator of homeostasis [1–3]. Heart rate variability (HRV)
is widely considered a standard noninvasive method for
assessing ANS function, due to ANS regulation of heart
rate in a continuous, beat-to-beat manner [4], with lower
HRV generally considered an indicator of poorer autonomic
function. Lower HRV or autonomic dysfunction has been
associated with several conditions of significant public health
concern, including diabetes and diseases of the cardiovascu-
lar system [5–11].
Obesity, an important risk factor for diabetes and car-
diovascular disease, is associated with dysregulation of auto-
nomic function. It has been suggested that ANS dysfunction
is an important mediator in the development of obesity-
associated disease and insulin resistance although the nature
of the link between adiposity and insulin sensitivity is still
unclear [12–15]. Studies of the relationship between body
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mass index (BMI) and HRV have reported conflicting results
with stronger associations observed in younger populations
[16–19]. Understanding the mechanism that connects obe-
sity and ANS function is important because of the increasing
obesity prevalence documented among men and women
of all ages [20]. One explanation for controversial data
on the associations between BMI and HRV is that the
distribution of body fat may be more important than a
measure of overall obesity, such as BMI, due to the metabolic
activity of visceral or abdominal adipose tissue [21–23].
This could be especially problematic in older persons for
whom BMI might be a poorer indicator of adiposity [24].
We hypothesized that central (abdominal) adiposity, not
overall adiposity, accounts for obesity-related autonomic
dysfunction. To examine this hypothesis, we compared the
strength of association between HRV and WC to that of
HRV and BMI, anticipating stronger, negative associations
between HRV and WC compared to that of HRV and BMI.
Furthermore, since obesity tends to be a stronger risk factor
for cardiovascular morbidity and mortality in young and
middle-aged persons than in older persons, we examined
whether WC and BMI relationships with ANS differ by age,
independent of specific health conditions known to impact
HRV.
2. Methods
2.1. Study Population. The Baltimore Longitudinal Study of
Aging (BLSA) is an observational study sponsored by the
National Institutes of Health and the National Institute on
Aging (NIA) that began in 1958 to study normative aging
in a volunteer cohort of healthy persons 18 years of age and
older at study entry [25]. Most BLSA participants reside in
the eastern USA, predominantly the Baltimore-Washington
DC area, and visit the NIA Advanced Studies in Translational
Research on Aging Unit every one to four years depending on
their age. In 2004, 24-hour ambulatory electrocardiograms
were implemented in the BLSA to assess HRV.
The first two hundred fourteen participants with Holter
data analyzed consecutively in the BLSA were evaluated.
These participants underwent a two-to-three day assessment
between March 2004 and March 2006, which included a bat-
tery of tests including a standardized medical examination
and interview, sociodemographic interview, anthropometric
assessment, fasting blood tests, and an oral glucose tolerance
test (OGTT) using a standard 75 gram glucose load. All
participants signed informed consent. This study complied
with the ethical rules for human experimentation as stated in
the Declaration of Helsinki and was approved by theMedStar
Research Institute institutional review board.
2.2. Outcomes: HRV Assessment. HRV was assessed from
ambulatory 24-hour Holter monitors that use digitalized
technology with compact flashcards and HRV software
(DelMar Reynolds Lifecard CF, 1024 samples per second,
Impresario software). An initial analysis was planned for
the first 200 recordings processed, and 214 had been
completed at the time of this analysis. All recordings were
visually reviewed and manually edited in a beat-by-beat
analysis using a standardized protocol to identify artifact and
nonsinus beats.
Exclusion criteria for HRV analysis on Holter data
were (1) implanted pacemakers, (2) transient or persistent
nonsinus rhythm during the recording, such as atrial
fibrillation, and (3) wandering atrial pacemakers (WAPs).
Although WAP is generally considered a benign condition,
it may produce invalid readings and constitutes a typical
exclusion [26–28]. HRVmeasures can be affected by frequent
premature beats, artifact, and total hours of recordings.
Thus, HRV data were excluded when recordings were less
than 18 hours, more than 10% of beats were premature, or
artifact time exceeded 5% of recorded time [4].
This analysis focused on standard time domain HRV
measurements, SDNN (standard deviation of successive dif-
ferences in normal-to-normal (N-N) intervals), and RMSSD
(root mean square of successive differences between N-
N intervals). SDNN represents a measure of overall ANS
function (sympathetic and some parasympathetic function)
while RMSSD represents a measure of parasympathetic
function [4]. Time domain measures have been suggested for
ambulatory studies as they are less susceptible to respiratory
and movement artifacts. Because HRV can be affected
by activity and sleep, SDNN and RMSSD were obtained
separately for day (6:00 AM–10:30 PM unless otherwise
reported in diary and was of similar hours) and night
(1:00 AM–5:00 AM). Nighttime hours were also selected to
provide a constant length of time for HRV analysis in which
participants were all sleeping.
The autonomic nervous system contributes to the cir-
cadian patterns of HRV with sympathetic nerve discharges
associated with activity, such as during daytime wakefulness
[29]. The circadian patterns of parasympathetic activity also
demonstrate a peak which occurs at night and plateaus
during the day [30]. Because of this, the HRV outcomes
of interest will focus on daytime SDNN, to describe overall
function, sympathetic more so than parasympathetic func-
tion, and nighttime RMSSD, to describe parasympathetic
function.
2.3. Predictors. Height, weight, and waist circumference,
(WC, centimeter, one inch above the anterior superior iliac
crests) were measured with participants disrobed or in
light clothes and barefoot. Height was measured using a
stadiometer. WC and height were measured three times and
averaged. BMI was calculated as weight in kilograms/height
in meters2 as a measure of overall adiposity whereas WC was
considered a measure of central or visceral adiposity. This
was based on findings from the Rancho Bernardo Heart and
Chronic Disease Study, which showed WC to be strongly
correlated with most measures of central obesity in men and
women aged 65–96 years [31].
2.4. Covariates. Conditions known to be associated with
HRV and body composition were assessed as covariates,
including glucose intolerance, hypertension, and physical
activity [10, 12, 32]. Glucose metabolism was assessed
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with a 2-hour oral glucose tolerance test (OGTT). Blood
pressure was taken using a manual sphygmomanometer with
the participant resting supine for 5 minutes in a quiet,
climate-controlled room with low lighting, using the first
and fifth Korotkoff sounds. The second and third systolic
blood pressure (SBP) and diastolic blood pressure (DBP)
measurements were averaged. Hypertension was defined as
use of antihypertensive medication, self-reported diagnosis
confirmed with medical record review, or SBP > 140mmHg
or DBP > 90mmHg during the physical examination. Dia-
betes was defined as use of hypoglycemic medications, self-
reported diagnosis of diabetes confirmed by medical records,
fasting glucose of 126mg/dL or greater, or a 2-hour OGTT
value ≥200mg/dL [33]. Angina and myocardial infarction
were assessed by self-report, review of medical records,
and by major Q-waves on resting electrocardiograms using
standard Minnesota Coding system criteria. Due to the
infrequent occurrence of diabetes, angina, and myocardial
infarction, analyses were conducted including and then
excluding participants with these conditions. Self-reported
physical activity was categorized by metabolic equivalents
per kg per week [34]. Age and race were obtained from
a standardized interview. Race was categorized as black
(self-reported race as “black” or “African American”) and
nonblack.
2.5. Statistical Analysis. Simple comparisons of continu-
ous variables by sex were performed with nonparametric
Wilcoxon tests and categorical variables with chi-square tests.
The correlation between continuous variables was assessed
using Spearman’s correlation coefficient. Because BMI and
WC have different units, we used standardized coefficients of
each to assess whether one was associatedmore with theHRV
outcomes than the other. Akaike’s Information Criterion
(AIC) was used to compare models (WC versus BMI), with
lower AIC indicating a better fitted model. To account for
nonnormal distributions of HRV, standard generalized linear
models with gamma distribution and log link were used to
assess relationships between adiposity measures (BMI and
WC) and HRV (nighttime RMSSD and daytime SDNN). To
determine whether these relationships differ by age, age-by-
BMI and age-by-WC interaction terms were included. All
models were adjusted for age, sex, race, physical activity, and
hyperglycemia using the OGTT 2-hour glucose. Previously
published studies suggest that HRV may differ across age
by sex and race, and some studies suggest that glucose
metabolism differs by sex [35, 36]. Thus, we also [34]
evaluated these interactions by including age-by-sex, age-by-
race, and sex-by-OGTT glucose terms. Significance level was
defined as P < .05.
Relationships were reported as relative ratios (RR), to
describe the multiplicative increases and decreases in HRV
associated with a unit change in the explanatory variable,
similar to a relative risk for binary data. For example, an RR
of 1.2 for male sex suggests a 20% higher HRV in men than
in women.
Lastly, because of the potential for beta blockers to
improve HRV [37], we repeated all analyses after excluding
participants on beta blockers. All analyses were conducted
using SAS 9.1 statistical software (SAS Institute Inc., Cary,
NC).
3. Results
Of 214 participants with Holter data, we excluded two
participants with recordings less than 18 hours, one with
nonsinus rhythm who also had a pacemaker, and 33 with
wandering atrial pacemakers, leaving 178 with HRV data.
Among these, nine were excluded from the OGTT (two
were taking insulin, six used corticosteroids in the previous
three months, and one refused). Of the 169 remaining
participants, three were missing data on WC and seven
were missing OGTT glucose due to difficult intravenous
access, leaving 159 participants for the current analysis. Of
these, one participant lacked a nighttime assessment. Only 15
participants (8%) were diabetic and 8 (4.5%) had angina or
myocardial infarction; 116 (65%) were hypertensive. Sixty-
seven participants (37%) were 70 years or older.
Characteristics of the 178 participants with valid HRV
data are presented in Table 1. Figure 1 shows histograms
of the HRV variables. The similarity between the lines
representing the gamma distribution and the kernel density
smoother of the actual data suggests a good fit of the gamma
model.
WC and BMI were significantly correlated (r = 0.73,
P < .0001). Despite this high correlation, a wide range of
WC was observed for any given BMI, suggesting that WC
describes potentially different information than BMI in this
population.
3.1. RMSSD (Parasympathetic ANS Function). The rela-
tionship between RMSSD and WC differed by age, with
RMSSD decreasing asWC increased in younger but not older
participants (P for interaction = 0.008) (Table 2 and Figure 2,
left panel). Figure 2 illustrates a comparison of the expected
nighttime RMSSD, based on model results, for an average
participant at two different ages: 45 years and 85 years if
the standardized WC increased. With increasing WC, the
RMSSD decreases in the 45-year-old but not in the 85-year-
old participant. In contrast, neither the main effect of BMI
nor the BMI-by-age interaction was statistically significant,
suggesting that BMI was not associated with RMSSD at
young or old ages (P = 0.403) (Figure 2, right panels).
Furthermore, the AIC for the RMSSD models suggested that
WC provided a better fitted model than did BMI (AIC = 819
versus 842).
3.2. SDNN (Overall ANS Function). Increasing WC was also
associated with decreasing SDNN in younger but not older
participants (P for interaction = 0.003) (Figure 2, Table 2).
There was no statistically significant association between
BMI and SDNN (Figure 2, Table 2). In addition, the model
fit for WC was superior to the model fit for BMI (AIC = 953
versus 982).
When participants with coronary artery disease or dia-
betes or those taking beta blockers were excluded, we found
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Figure 1: Histograms of heart rate variability variables with a smooth kernel density estimate (dashed line) and gamma distribution (solid
line). RMSSD: root mean square of successive differences; SDNN: standard deviation of N-N intervals.
Table 1: Sample characteristics stratified by sex.
Women (n = 90) Men (n = 88) P value
Mean (SD) or N (%)
SDNN (ms2) 103 (25.6) 110 (30.0) 0.096
RMSSD (ms2) 30 (14.6) 30 (16.7) 0.815
Age years 64 (14.3) 66 (11.8) 0.198
Systolic blood pressure (mmHg) 119 (16.6) 123 (14.2) 0.107
Body mass index (kg/m2) 27 (4.9) 27 (3.9) 0.226
Waist circumference (cm) 88 (14.0) 98 (12.9) <0.001
Fasting glucose (mg/dL) 93 (13.1) 98 (17.7) 0.026
OGTT 2-hour glucose (mg/dL) 118 (43.5) 133 (54.7) 0.067
Black race† 26 (29%) 24 (26%) 0.681
Antihypertensive use 40 (44%) 46 (52%) 0.371
Beta blocker use 16 (18%) 21 (24%) 0.317
Hypertension 50 (56%) 56 (63%) 0.353
†
Self-reported race/ethnicity (N) included: Caucasian (118), black or African American (50), Asian or Pacific islanders (4), American Indian or native Alaskan
(1), Hispanic (2), Chinese (3), and other or unknown (1).
ms:milliseconds; OGTT: oral glucose tolerance test; RMSSD: root mean square of successive differences in normal-to-normal intervals; SDNN: standard
deviation of normal-to-normal intervals.
similar results for both SDNN and RMSSD. Specifically,
the parameter estimates remained similar, and statistical
significance was unchanged despite a smaller sample (data
not shown).
4. Discussion
To our knowledge, this is the first study to assess the roles
of overall and abdominal adiposity on ANS function in
young and old persons. The findings showed that central
adiposity, measured by waist circumference, was associated
with poorer ANS function at younger but not older ages.
This relationship was observed for a measure of overall ANS
function that includes sympathetic and parasympathetic
activity and for a measure of primarily parasympathetic
activity. Overall adiposity, measured using BMI, was not
associated with either measure of ANS function. Thus,
abdominal adiposity, as opposed to overall adiposity tissue,
could adversely affect ANS function at younger ages with
potentially unfavorable effects in later life.
Our results are in accordance with a small study by
Christou et al. [38], which reported higher abdominal-to-
peripheral body fat distributions measured by DXA were
strongly correlated with lower sympathetic and parasympa-
thetic function in young (mean age 25 ± 1 year) and old
(mean age 65 ± 1 year) healthy men. Other studies have
also shown that body fat distribution accounts for obesity-
associated risk more so than total fat, with visceral fat car-
rying the greatest risk for insulin resistance, hyperglycemia,
hypertriglyceridemia, cardiovascular disease, metabolic syn-
drome, and mortality [22, 23, 39–41]. Our findings suggest
that abdominal adiposity may also contribute to poorer
sympathetic and parasympathetic function as well.
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Figure 2: Data points are observed data; lines represent the predicted value of nighttime RMSSD (top row) and daytime SDNN (bottom row)
(if the adiposity measure increased for an average participant at two ages: 45 years (solid lines) and 85 years (dashed lines)). Standardized
waist circumference and standardized BMI are shown on x-axes to scale the measures similarly. The figures show differing relationships
between waist circumference and HRV measures at young and old ages but not between BMI and HRV measures. Negative relationships
were observed between waist circumference and RMSSD and SDNN in the 45 yo but no significant relationship in the 85 yo. Comparatively,
the SDNN-BMI relationship is attenuated, compared to WC, for the 45-year olds and the RMSSD-BMI relationship is relatively flat at 45
and 85 years, with neither being statistically significant. ∗x-axes are standard deviations from mean waist circumference (women: 88 cm,
men: 98 cm) or BMI (27 kg/m2). ∗Graded gray-scale data points from population illustrate increasing age (lighter is younger, darker is
older, 26–96 y). Models were adjusted for sex, race, OGTT glucose, blood pressure, and the interactions age-by-sex, age-by-race, the sex-
by-OGTT glucose. OGTT glucose = 2-hour oral glucose tolerance test glucose result; RMSSD:root mean square of successive differences;
SDNN:standard deviation of N-N intervals.
The relationship between central adiposity and ANS
function is not a surprising finding. The ANS innervates fat
depots, which are positively associated with catecholamine
production by the ANS [42, 43]. The biologic mechanisms
whereby visceral fat could contribute to ANS dysfunction
could involve adipocytokines secreted by fat cells [44, 45].
Although metabolic activity of central adipose tissue could
account for the associations between ANS function and
obesity, lack of association with BMI at older ages could
be explained by the poor ability of BMI to accurately
reflect body fat at older age [24]. This does not explain,
however, the lack of associations observed in young persons.
Future studies should examine the role of adipocytokines in
mediating the effects of obesity on ANS function.
The lack of association for either measure of obesity at
older ages supports recent arguments that “a little extra”
around the middle may be good for older adults, or at
least not as harmful as in young and middle age [46, 47].
Our findings lend some support for this or, at least, fail
to demonstrate that central adiposity, within the range
observed in this population, was associated with poorer ANS
function in the oldest participants. In contrast, younger
participants with more central adiposity appeared to have
ANS function similar to older participants, that is, premature
aging of the ANS.
The long-term sequelae of impaired ANS function
manifested as lower HRV are unknown but could contribute
to cardiovascular, lipid, and endocrine abnormalities as
these mechanisms are regulated by the ANS. Evidence for
this includes studies that demonstrate associations between
lower HRV and coronary artery disease, heart failure,
hyperlipidemia, hypertension, and prediabetic and diabetic
states [9–11, 13, 48, 49]. Additionally, the relationship
between central adiposity and ANS function observed in
this study independent of blood pressure and glucose could
explain how three of the most important components of
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Table 2: Relative risks (RR) percent change in SDNN and RMSSD for each standard deviation increase in the obesity variables: waist
circumference (WC) and body mass index (BMI). Smaller Akaike’s Information Criterion (AIC) indicates better fitted models.
A. WC model Night RMSSD Day SDNN
RR RR
(95% CI) P value (95% CI) P value
Age (per 10 year) 0.41 0.64
(0.23, 0.75) 0.004 (0.48, 0.85), 0.002
Waist circumference (per 5 cm) 0.73 0.85
(0.58, 0.92) 0.008 ( 0.76, 0.95), 0.005
Age-by-waist circumference 1.05 1.02
(1.01, 1.08) 0.008 (1.01, 1.04), 0.004
AIC 819 953
B. BMI model Night RMSSD Day SDNN
RR RR
(95% CI) P value (95% CI) P value
Age (per 10 year) 1.10 0.89
(0.71, 1.68), 0.673 (0.72, 1.10), 0.300
Body mass index (BMI) 1.04 0.98
(0.93, 1.17), 0.496 (0.92, 1.03), 0.404
Age-by-BMI 0.99 1.00
(0.98, 1.01), 0.403 (0.999, 1.01), 0.428
AIC 842 982
Models adjusted for sex, race, blood pressure, oral glucose tolerance test (OGTT) 2-hour glucose, age-by-race, age-by-sex, OGTT 2-hour glucose-by-sex, and
physical activity.
RR:relative risk;SDNN:standard deviation of normal-to-normal intervals.RMSSD:root mean square of successive differences in normal-to-normal intervals.
the metabolic syndrome (i.e., hypertension, diabetes, and
obesity) act synergistically on the cardiovascular system—
that is, through the derangement of ANS function.
Regarding limitations, this study included a relatively
small sample in a cross-sectional analysis. However, the
BLSA is an ongoing study so future analyses will assess
the robustness of these findings both cross-sectionally and
longitudinally. Study participants were in relatively good
health. Consequently, findings may not be generalizable to
persons in poorer health. Nevertheless, observing the asso-
ciation between WC and HRV in healthy persons suggests
that ANS dysfunction can be detected early and at relatively
young ages, therefore providing an opportunity for early
intervention. The cross-sectional design limits our ability
to establish causal relationships, and, in fact, one hypoth-
esis proposes that central effects of adipocytokines could
alter sympathetic and parasympathetic balance, leading to
changes in the distribution of visceral and subcutaneous fat
[50]. Nevertheless, our findings provide important clues to
guide future studies. For instance, longitudinal analyses will
be conducted to determine how changes in WC and ANS
function at younger ages contribute to health risk in late life.
In summary, we observed an inverse association between
central adiposity measured by WC and ANS function at
young and middle but not old-age. This was true for a
measure of primarily parasympathetic function (RMSSD) as
well as a measure of mixed sympathetic and parasympathetic
function (SDNN). BMI was not associated with ANS func-
tion in this study. Future studies should examine whether
metabolic activity of central adipose tissue explains these
associations.
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